Literature DB >> 16154209

Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins.

H Takase1, C-R Yu, X Liu, C Fujimoto, I Gery, C E Egwuagu.   

Abstract

Suppressors of cytokine signaling (SOCS) are implicated in immunopathogenic mechanisms of autoimmune diseases. We show here that SOCS expression in retina is temporarily correlated with progression of experimental autoimmune uveitis (EAU), an organ-specific autoimmune disease that serves as model of human uveitis. Peak of EAU correlates with highest SOCS genes expression while disease resolution coincides with their down-regulation. Surprisingly, SOCS5 is constitutively expressed in retina. SOCS5 expression increases significantly during EAU and remains elevated even after disease resolution. Our data suggest that cytokine-inducible SOCS members may be involved in negative regulation of inflammatory cytokines activities during EAU, while constitutively expressed SOCS5 may have neuroprotective functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16154209     DOI: 10.1016/j.jneuroim.2005.07.021

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  19 in total

1.  Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms.

Authors:  Hyun-Mee Oh; Cheng-Rong Yu; Yongjun Lee; Chi-Chao Chan; Arvydas Maminishkis; Charles E Egwuagu
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

2.  Retinal Astrocytes respond to IL-17 differently than Retinal Pigment Epithelial cells.

Authors:  Yan Ke; Guomin Jiang; Deming Sun; Henry J Kaplan; Hui Shao
Journal:  J Leukoc Biol       Date:  2009-08-18       Impact factor: 4.962

3.  Environmental factors determine DAP12 deficiency to either enhance or suppress immunopathogenic processes.

Authors:  Vanessa Montalvo; Laura Quigley; Barbara P Vistica; Kimberly C Boelte; Lindsey F Nugent; Toshiyuki Takai; Daniel W McVicar; Igal Gery
Journal:  Immunology       Date:  2013-12       Impact factor: 7.397

4.  Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10.

Authors:  Yun Sang Lee; Ahjoku Amadi-Obi; Cheng-Rong Yu; Charles E Egwuagu
Journal:  Immunology       Date:  2011-02-07       Impact factor: 7.397

5.  Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis.

Authors:  Chang He; Cheng-Rong Yu; Lin Sun; Rashid M Mahdi; Joseph Larkin; Charles E Egwuagu
Journal:  J Autoimmun       Date:  2015-06-19       Impact factor: 7.094

6.  Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells.

Authors:  Xuebin Liu; Marie G Mameza; Yun Sang Lee; Chikezie I Eseonu; Cheng-Rong Yu; Jennifer J Kang Derwent; Charles E Egwuagu
Journal:  Diabetes       Date:  2008-03-20       Impact factor: 9.461

7.  Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases.

Authors:  Xuebin Liu; Yun Sang Lee; Cheng-Rong Yu; Charles E Egwuagu
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 8.  Role of the retinal vascular endothelial cell in ocular disease.

Authors:  Arpita S Bharadwaj; Binoy Appukuttan; Phillip A Wilmarth; Yuzhen Pan; Andrew J Stempel; Timothy J Chipps; Eric E Benedetti; David O Zamora; Dongseok Choi; Larry L David; Justine R Smith
Journal:  Prog Retin Eye Res       Date:  2012-09-11       Impact factor: 21.198

9.  Unlike Th1, Th17 cells mediate sustained autoimmune inflammation and are highly resistant to restimulation-induced cell death.

Authors:  Guangpu Shi; Madhu Ramaswamy; Barbara P Vistica; Catherine A Cox; Cuiyan Tan; Eric F Wawrousek; Richard M Siegel; Igal Gery
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

10.  SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.

Authors:  Cheng-Rong Yu; Sung-Hye Kim; Rashid M Mahdi; Charles E Egwuagu
Journal:  J Immunol       Date:  2013-10-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.